BeOne Medicines EPS Diluted from Extraordinaries (Quarterly) Analysis

BeOne Medicines Ltd. (ONC)

358.31 +3.83 (+1.08%) USD | NASDAQ | Feb 20, 10:51

View EPS Diluted from Extraordinaries (Quarterly) for ONC.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View EPS Diluted from Extraordinaries (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View EPS Diluted from Extraordinaries (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View EPS Diluted from Extraordinaries (Quarterly) Benchmarks

Start Trial

Jazz Pharmaceuticals Plc	--
EvoNext Holdings SA	--
Kuros Biosciences Ltd.	--
Basilea Pharmaceutica AG	--
Santhera Pharmaceuticals Holding AG	--